2022
DOI: 10.1016/j.neubiorev.2022.104578
|View full text |Cite
|
Sign up to set email alerts
|

Treatment-resistant depression with anhedonia: Integrating clinical and preclinical approaches to investigate distinct phenotypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(5 citation statements)
references
References 104 publications
0
5
0
Order By: Relevance
“…This novel form of intervention is predicted to be effective in the management of patients with TRD, in which non-monoaminergic drugs have better chances of success. Our findings lay the groundwork for an in-depth analysis of the synergism between LAC and MF in additional preclinical models, such as 1) models that are able to identify groups of animals resilient to both acute ( Torrisi et al, 2020 ) and chronic ( Dziedzicka-Wasylewska et al, 2021 ) stress; 2) models in which LAC and MF are combined with subthreshold doses of conventional antidepressants (e.g., SSRIs or SNRIs); and, 3) experimental animal models of TRD, characterized by a reduced or absent response to antidepressants ( Planchez et al, 2019 ; Kelly et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…This novel form of intervention is predicted to be effective in the management of patients with TRD, in which non-monoaminergic drugs have better chances of success. Our findings lay the groundwork for an in-depth analysis of the synergism between LAC and MF in additional preclinical models, such as 1) models that are able to identify groups of animals resilient to both acute ( Torrisi et al, 2020 ) and chronic ( Dziedzicka-Wasylewska et al, 2021 ) stress; 2) models in which LAC and MF are combined with subthreshold doses of conventional antidepressants (e.g., SSRIs or SNRIs); and, 3) experimental animal models of TRD, characterized by a reduced or absent response to antidepressants ( Planchez et al, 2019 ; Kelly et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Mood shows the clustering of multiple dimensions of depression, instead of a distinction between i.e. depressed mood and anhedonia, which is known to have poorer prognosis (Kelly et al, 2022). The self-image profile, however, may have the highest transdiagnostic value, because it is composed of at least one item of every questionnaire.…”
Section: Expression Of Transdiagnostic Symptom Profilesmentioning
confidence: 99%
“…Moreover, intervention studies in marmoset monkeys provide evidence for the causal role of overactivation of area 25 within caudal scACC (scACC-25) in the symptoms of depression and anxiety. Specifically, scACC-25 overactivation induces anticipatory and motivational anhedonia ( Alexander et al, 2018 ), a major symptom of depression and especially common in treatment resistant patients ( Kelly et al, 2022 ; Słupski et al, 2020 ). It also heightens reactivity to uncertain threat, causes generalisation of conditioned threat responses and increases sympathetic cardiovascular activity alongside reduced heart rate variability ( Alexander et al, 2020 ); symptoms commonly reported in generalised anxiety disorder ( Hur et al, 2020 ; Pittig et al, 2013 ).…”
Section: Introductionmentioning
confidence: 99%